FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2026
Back to search
Official data from USPTO
SEQURNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEQURNA
ST13
US500000079398350Class
1, 5, 10, 42
Filing
79398350
Registration
7830597
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 10, 42
Filing date
02/13/2024
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
SE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SEQURNA AB
SEQURNA AB
Representatives
Thomas Y. Yee Perkins Coie LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for medical research; diagnostic reagents for scientific use; reagents for research purposes.
Class 5
Reagents for medical use; clinical diagnostic reagents for medical use; diagnostic reagents for medical use; reagents for use with analyzers for medical purposes; diagnostic biomarker reagents for medical purposes; clinical medical reagents; reagent paper for medical purposes; RNase inhibitors for medical purposes
Class 10
Medical instrumentsvials containing RNase inhibitors used for RNA sequencing; instruments for use in medical analysisvials containing RNase inhibitors used for RNA sequencing; testing instruments for medical purposesvials containing RNase inhibitors used for RNA sequencing; diagnostic instruments for medical purposesvials containing RNase inhibitors used for RNA sequencing; apparatus for DNA and RNA exams for medical purposes; capillary tubes for delivering reagents for medical use
Class 42
Scientificmedical and pharmaceutical research and development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to molecular biology and biomedicine; medical and scientific consulting services in the fields of molecular biology and biomedicine; providing medical and scientific research information in the field of molecular biology and biomedicine; pharmaceutical and scientific research and development; laboratory diagnosticsmedical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories; medical and scientific informationadvisory and consultancy services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/16/2026
FIMP
FINAL DISPOSITION PROCESSED
01/16/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/17/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/31/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/31/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/31/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/31/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/20/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/20/2024
RFNT
REFUSAL PROCESSED BY IB
10/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/14/2024
RFRR
REFUSAL PROCESSED BY MPU
09/14/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/12/2024
CNRT
NON-FINAL ACTION WRITTEN
09/11/2024
DOCK
ASSIGNED TO EXAMINER
09/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2024
Continuous trademark protection
Get notified about every new filing that threatens SEQURNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.